GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · IEX Real-Time Price · USD
2.800
-0.120 (-4.11%)
At close: Jul 19, 2024, 4:00 PM
2.710
-0.090 (-3.21%)
Pre-market: Jul 22, 2024, 9:02 AM EDT
GeoVax Labs Employees
GeoVax Labs had 17 employees as of December 31, 2023. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
n/a
Profits / Employee
-$1,634,058
Market Cap
12.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Universe Pharmaceuticals INC | 225 |
Psychemedics | 116 |
Flora Growth | 108 |
Imunon | 33 |
NEXGEL | 19 |
Avalo Therapeutics | 19 |
NeuroSense Therapeutics | 18 |
BriaCell Therapeutics | 16 |
GOVX News
- 3 months ago - GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine - GlobeNewsWire
- 4 months ago - GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress - GlobeNewsWire
- 4 months ago - GeoVax to Present at the 36th Annual Roth Conference - GlobeNewsWire
- 4 months ago - GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System - GlobeNewsWire
- 5 months ago - GeoVax Reports 2023 Year-End Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 - GlobeNewsWire
- 5 months ago - GeoVax to Present at the 2024 BIO CEO & Investor Conference - GlobeNewsWire
- 5 months ago - GeoVax Announces Multiple Patent Issuances and Allowances - GlobeNewsWire